Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Cellular & Molecular Biology Letters

Fig. 3

From: N6-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing

Fig. 3

SRPK1 is the potential target of METTL3 in LUAD. A Flowchart for screening potential targets of METTL3. B Venn diagram of genes with differential m6A quantity, m6A level, and mRNA expression. C Heatmap of m6A levels of related genes in the microarray. D Bar chart of related genes expression in the TCGA database. E The H1299 cell’s m6A levels of E2F8 were determined by MeRIP–qPCR. F The A549 and H1299 cell’s m6A level of SRPK1 was assessed by MeRIP–qPCR. *< 0.05; **< 0.01

Back to article page